← Leaderboards
Edward F Rosloniec
University Of Tennessee Health Sci Ctr
$681,511
Attributed
$681,511
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $166.3K · FY2011–20$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$681,511 · 3
VA$0 · 3
By mechanism
R01$376,591 · 1
R21$304,920 · 1
I01$0 · 2
IP1$0 · 1
P30$0 · 1
Top collaborators
- David D. Brand4 shared
- Arnold E Postlethwaite4 shared
- John M Stuart4 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- James B. Dale$12,650,560
- Arnold E Postlethwaite$3,571,879
- Gadiparthi N Rao$27,893,715
- Anjaparavanda P Naren$16,948,975
- Wei Li$11,377,399
Others in their field
Top investigators on “Rheumatoid Arthritis”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Lionel B Ivashkiv · Hospital For Special Surgery$38,096,851
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- V Michael Holers · University Of Colorado Denver$28,178,502
- Michael B Brenner · Brigham And Women'S Hospital$26,598,289
- Betty Diamond · Feinstein Institute For Medical Research$20,428,564
Research focus
Rheumatoid ArthritisAutoimmunityPeptidesMouse ModelArthritisAutoimmune DiseasesLeadAutoimmune ProcessPredispositionMediatingFlow CytometryAutoantigensInflammationSignal TransductionResponseT-LymphocyteHla-Dr1 AntigenAutoimmune ArthritisHla-Dr AntigensCd4 Positive T LymphocytesComplexBaseDr1 GeneTnfrsf10a Gene
Grant awards (18)
Neo-antigens and the function of HLA-DR alleles in autoimmune arthritis$0
I01 · FY2020 · VA · contact PI
Neo-antigens and the function of HLA-DR alleles in autoimmune arthritis$0
I01 · FY2019 · VA · contact PI
Chimeric antigen receptor (CAR) therapy for autoimmune arthritis$166,320
R21 · FY2018 · AR · contact PI
Neo-antigens and the function of HLA-DR alleles in autoimmune arthritis$0
I01 · FY2018 · VA · contact PI
Chimeric antigen receptor (CAR) therapy for autoimmune arthritis$138,600
R21 · FY2017 · AR · contact PI
Neo-antigens and the function of HLA-DR alleles in autoimmune arthritis$0
I01 · FY2017 · VA · contact PI
Program Project for Mechanisms and Treatment of Arthritis$0
IP1 · FY2016 · VA
Program Project for Mechanisms and Treatment of Arthritis$0
IP1 · FY2015 · VA
Program Project for Mechanisms and Treatment of Arthritis$0
IP1 · FY2014 · VA
Structure-function of HLA-DR, peptides, and T cells in autoimmune arthritis$0
I01 · FY2014 · VA · contact PI
Structure-function of HLA-DR, peptides, and T cells in autoimmune arthritis$0
I01 · FY2013 · VA · contact PI
Program Project for Mechanisms and Treatment of Arthritis$0
IP1 · FY2013 · VA
Structure-function of HLA-DR, peptides, and T cells in autoimmune arthritis$0
I01 · FY2012 · VA · contact PI
Structure-function of HLA-DR, peptides, and T cells in autoimmune arthritis$0
I01 · FY2011 · VA · contact PI
CORE--ANIMAL RESOURCE CORE(ARC) OF THE RDRCC$0
P30 · FY2002 · AR
MECHANISMS OF AUTOIMMUNE ARTHRITIS$191,062
R01 · FY2001 · AR
CORE--ANIMAL RESOURCE CORE(ARC) OF THE RDRCC$0
P30 · FY2001 · AR
MECHANISMS OF AUTOIMMUNE ARTHRITIS$185,529
R01 · FY2000 · AR